-
President of Saudi Society of Clincal Pharmacy Speech
19:20 - 19:30
Prof. Ahmed Aljedai
-
Keynote Speech: Executive President of Saudi Food & Drug Authority
19:40 - 19:50
H.E. Prof. Hisham Aljadhey
-
Keynote Speech: Assistant Minister of Health for Health Services
19:50 - 20:00
Dr. Mohammed AlAbdulaali
-
AI-Augmented Clinical Decision Support: From Alerts to Actionable Insights
08:30 - 08:50
Dr. Mohammed Alhefzi
-
AI-Driven Market Access in Saudi Arabia and Leveraging AI for Competitive Advantage in the GCC
08:50 - 09:10
Dr. Anas Alsudays
-
Beyond the Infusion Chair: How Artificial Intelligence and Digital Pharmacy Are Redefining Cancer Care at Home
09:10 - 09:30
Dr. Waad Alhuqbani
-
Q&A
09:30 - 09:40
-
Coffee Break
09:40 - 09:50
-
The Security Risks of Artificial Intelligence Applications on the Healthcare System
09:50 - 10:30
Prof. Amr Jamal - Dr. Nasser Aljehani - Dr. Abdulaziz Alhomod
-
Prayer & Lunch Break
12:00 - 13:00
-
Pharmacy at the Heart of Saudi Vision 2030: Innovation, Localization, and Impact
13:00 - 13:50
Eng. Meraee AL-Qahtani - Prof. Ahmed Aljedai - Dr. Ahmed Alshamrani - Dr. Ibrahim Aljuffali - Dr. Mohammed Alshennawi
-
Coffee Break
13:50 - 14:00
-
The Evolving Role of Clinical Trials as a National Pillar
14:00 - 14:20
Dr. Khalid Alamer
-
RWE-Driven Pharmacovigilance: Active and Passive Surveillance
14:20 - 14:40
Dr. Eman Alghamdi
-
Using Real-World Data to Optimize Pharmacotherapy Outcomes Across Health Systems
14:40 - 15:00
Dr. Ibrahim Asiri
-
Data to Decisions: Leveraging Registries, EHRs, and National Databases for Pharmacy Impact
15:00 - 15:20
Dr. Wejdan Aburas
-
Coffee Break
15:20 - 15:30
-
Debate 1: Clinical Trials or Real-World Evidence: Which Should Drive Therapeutic Decision-Making Today?
15:30 - 16:20
Dr. Lubna Alnasser - Dr. Mohammed Boaseed
-
Organizational and Individual Supports for Well-being in the Context of Clinical Practice and Research
09:00 - 09:20
Dr. Fadiah Alkhattabi
-
Measuring What Matters: A Local Journey in Building Clinical Pharmacists’ KPIs and Performance Metrics
09:20 - 09:40
Dr. Mohammad Alsharhan
-
Developing the Next Generation of Clinical Pharmacy Leaders: Building Sustainable Clinical, Academic, and Research Excellence
09:40 - 10:00
Dr. Bassam Atallah
-
Q&A
10:00 - 10:10
-
Empowering GCC Clinical Pharmacy
10:10- 11:00
Dr. Mohammed Alnahedh - Dr. Maha Fansa - Dr. Fatema Fakhra - Dr. Rana Aljaber - Dr. Bassam Atallah
-
Prayer & Lunch Break
11:00 - 13:30
-
Investment and Localization opportunities, Venture Capital Ecosystems and Regulations
14:30 - 15:20
Eng. Nizar Al Hariri - Dr. Ashraf Algrain - Dr. Mazen Hassanain - Dr. Ibrahim Alnajashi
-
Coffee Break
15:20 - 15:30
-
Medicines Optimization: Transforming Polypharmacy Management, Deprescribing, and Shared Clinical Decision-Making
15:30 - 15:50
Dr. Asma Yahyouche
-
Translating Digital Health and AI into Measurable Clinical Impact
15:50- 16:10
Dr. Ammar Hejazi
-
Sustainable Pharmacotherapy Models: Optimizing Value, Access, and Resource Utilization at Scale
16:10- 16:30
Dr. Nada Alagil
-
Medication Shortages in Healthcare: Strategic Solutions and the Role of Supply Chain Leadership
16:30 - 16:50
Dr. Ayman Allam
-
Beyond the Hospital: The Hidden Clinical Power of Pharmacists in Insurance
16:50 - 17:10
Dr. Sana Alwafae
-
Q&A
17:10 - 17:20
-
Transforming the Treatment Landscape of Pediatric Sickle Cell Disease and Thalassemia
08:00 - 08:20
Dr. Afnan Alsunaidi
-
Pharmacologic Management of Pediatric Obesity: Evidence, Ethics, and Long-Term Outcomes
08:20 - 08:40
Dr. Hessa Almuqati
-
Maternal Vaccination vs. Neonatal Immuno-prophylaxis for RSV
08:40 - 09:00
Dr. Shaima Alshareef
-
Disease-Modifying Therapy in Pediatric Hematology: Optimizing Outcomes Beyond Transfusions
09:00 - 09:20
Dr. Dema Almolaiki
-
Prioritizing Access to Modern Gene Therapies and Management Strategies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy
09:20 - 09:40
Dr. Abdullah Almalki
-
Q&A
09:40 - 09:50
-
Coffee Break
09:50 - 10:00
-
Advancing Personalized Care in Non-Small Cell Lung Cancer
10:00 - 10:20
Dr. Mashael Alrouqi
-
BTK Inhibitors in CLL: Cardiovascular Risk, Bleeding, and Drug–Drug Interactions
10:20 - 10:40
Dr. Jude Bin Howaidi
-
Role of Maintenance Therapy in HER2+ Breast Cancer
10:40 - 11:00
Dr. Ahmed Alanazi
-
Strategic Formulary Management in Oncology
11:00 - 11:20
Dr. Rana Aljaber
-
Q&A
11:20 - 11:30
-
Advancing Pharmacy Education and Academic Pathways for Global Healthcare Impact
11:30 - 12:20
Prof. Yousif Asiri - Prof. Abdulkareem Albekairy - Prof. Amer Alanazi - Dr. Ahmed Aldemerdash
-
Prayer & Lunch Break
12:20 - 13:30
-
Modern Management of Rheumatoid Arthritis: Positioning JAK and IL-6 Inhibitors in Internal Medicine Practice
10:30- 10:50
Dr. Reem Qubaiban
-
Beyond Conventional Therapy in IBD: The Case for Early Biologics and Small Molecules
10:50 - 11:10
Dr. Anfal AlAli
-
Steroid-Sparing Strategies in Severe Asthma: Biologic Therapy in Real-World Internal Medicine Practice
11:10 - 11:30
Dr. Abdulaziz Jaly
-
The Role of Terlipressin in Hepatorenal Syndrome
11:30 - 11:50
Dr. Maha Fansa
-
Q&A
11:50 - 12:00
-
Prayer & Lunch Break
12:00 - 13:30
-
Toxicological and Poisonous Emergencies
13:30- 13:50
Prof. Hussain Bakhsh
-
Clinical pharmacists’ Role in IV Fluid Stewardship: how can we contribute?
13:50 - 14:10
Dr. Fatema Fakhra
-
Life-Threatening Metabolic Crises in Critical Care: Pharmacologic Pitfalls and Best Practices
14:10 - 14:30
Dr. Razan Alghunaim
-
Sepsis Management Guidelines Updates
14:30 - 14:50
Dr. Rahaf Alqahtani
-
Q&A
14:50 - 15:00
-
Coffee Break
15:00 - 15:30
-
CRAB in the ICU: Targeted Therapy for One of the World’s Most Resistant Pathogens
15:30- 15:50
Dr. Hibah Alruwaisan
-
Beyond the Microbiome: 'Next-Gen" CDI Prevention
15:50 - 16:10
Dr. Sameer Alzaidi
-
New Antibiotics, New Challenges: Integrating Emerging Antimicrobials into Clinical Practice
16:10 - 16:30
Dr. Hussain Alali
-
Combination Therapy for MDR Gram-Negative Infections in Critically Ill Patients: Necessary Standard or Unnecessary Overtreatment
16:30 - 16:50
Dr. Majid Almajid
-
Q&A
16:50 - 17:00
-
Medication Safety Reporting and Quality Metrics
09:00 - 09:20
Dr. Salma Alkhani
-
Technology isn’t Enough: Making Medication Safety Systems Actually Work
09:20 - 09:40
Dr. Fahad Alkhuzaee
-
Clinical Application of Pharmacogenomics
09:40 - 10:00
Dr. Mohamed Nagy
-
Biosimilars Beyond Cost Savings: Ensuring Safe Adoption, Switching, and Sustainability in Healthcare Systems
10:00 - 10:20
Dr. Mohammed Ahmed
-
Translating Liposomal Drug Delivery into Clinical Outcomes: From Formulation Design to Patient Impact
10:20 - 10:40
Dr. Abdullah Aljasser
-
Q&A
10:40 - 11:00
-
Prayer & Lunch Break
11:00 - 13:30
-
Pharmacological Management of HFpEF and HFmrEF: Beyond Symptom Control
13:30- 13:50
Dr. Ehsan Habeeb
-
Approaches to Stroke Prevention in Atrial Fibrillation: Device or Drug?
13:50 - 14:10
Dr. Mossab Aljuaid
-
When Cancer Therapy Targets the Heart: Prevention and Management of Immune-Mediated Cardiotoxicity
14:10 - 14:30
Dr. Hadi Skouri
-
Beyond Vasodilation in Pulmonary Arterial Hypertension: Targeting Vascular Remodeling and Right Heart Failure
14:30 - 14:50
Dr. Rana Alruwaisan
-
Q&A
14:50 - 15:00
-
Coffee Break
15:00 - 15:30
-
Slowing CKD Progression in Ambulatory Care: Practical Integration of SGLT2 Inhibitors and Finerenone in Real-World Practice
15:30- 15:50
Dr. Mohammed Abutaleb
-
Improving Outcomes in Osteoporosis: Long-Acting Therapies, Adherence, and Fracture Prevention in Ambulatory Care
15:50 - 16:10
Dr. Fatimah Aljohani
-
Improving Medication Adherence in Chronic Disease: Digital Health, Behavioral Interventions, and Pharmacist-Led Models
16:10 - 16:30
Dr. Abdulaziz Alhossan
-
Q&A
16:30 - 16:40
-
Hypertension Beyond Daily Pills: Are Long-Acting and Device-Based Therapies Ready for Ambulatory Practice?
16:40- 17:30
Dr. Fahad Aldosari - Dr. Alaa Abuzaid - Dr. Raghad Alsaif
-
Building Excellence: Establishing a Solid Organ Transplant Pharmacotherapy Service from Bedside to Clinic
08:00- 08:20
Dr. Sahar Almowaina
-
Precision Transplant Medicine: Pharmacogenomics, and Biomarker-Guided Immunosuppression
08:20 - 08:40
Dr. Delal Alkortas
-
Infection Management in 2026: CMV, BK Virus, and Emerging Resistant Pathogens in the Era of Novel Therapies
08:40 - 09:00
Dr. Abdulmalik Alotaibi
-
Q&A
09:00 - 09:10
-
The Future of Transplantation Tolerance, Xenotransplantation, and AI-Driven Care: Are We Ready?
09:10 - 10:00
Dr. Sahar Almowaine - Dr. Delal Alkortas - Dr. Abdulmalik Alotaibi
